JP Morgan Chase’s CAMP4 Therapeutics CAMP Stock Holding History
Bought
Maintained
Sold
Other funds holding CAMP
JP Morgan Chase's CAMP Position: Q3 2026 in Review
JP Morgan Chase increased its CAMP4 Therapeutics (CAMP) stake by 14% in Q3 2026, buying an estimated $7.67K and bringing the position to 14,985 shares worth $58.6K. The position accounts for ﹤0.01% of the portfolio, ranked #6503.
JP Morgan Chase first reported a position in CAMP in Q4 2024 and has held it in 5 quarters since. The position peaked at $111K in Q4 2024. 69 funds tracked by Wall St. Rank hold CAMP as of Q3 2026.
- JP Morgan Chase held 14,985 shares of CAMP4 Therapeutics worth $58.6K as of Q3 2026.
- JP Morgan Chase bought 1,869 CAMP4 Therapeutics shares in Q3 2026, an estimated $7.67K.
- CAMP4 Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #6503 holding.
- JP Morgan Chase first reported a position in CAMP4 Therapeutics in Q4 2024 and has held it in 5 quarters since.
- JP Morgan Chase's CAMP4 Therapeutics position peaked at $111K in Q4 2024.
- 69 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q3 2026.
Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.